Pulmonary Hypertension Biorepository and Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-08-10

Study Completion Date

2027-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Quantitative Pulmonary Imaging Registry & Biorepository

NCT05530408

Pulmonary Disease

RECRUITING

Registry for Pulmonary Hypertension in China

NCT01417338

Pulmonary Arterial Hypertension Chronic Thromboembolic Pulmonary Hypertension Death

UNKNOWN

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

NCT01730092

Pulmonary Disease Pulmonary Hypertension

RECRUITING

Vascular Subphenotypes of Lung Disease in HIV & COPD

NCT01581086

Pulmonary Artery Hypertension

COMPLETED

Emphysema Research Registry and Biosample Repository

NCT00307281

Emphysema Chronic Obstructive Pulmonary Disease Chronic Bronchitis

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this project will be to establish a broad and wide-ranging registry and biorepository of blood samples from patients with pulmonary hypertension, including all WHO groups I-V to be used for future research in these areas. This will be both a retrospective and prospective project. The registry and biorepository will be utilized to study and grow our knowledge of the cellular mechanisms and mediators of the disease and, in turn, contribute to advancements in treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Hypertension Pulmonary Arterial Hypertension Pulmonary Hypertension Due to Left Heart Disease Pulmonary Hypertension, Primary Pulmonary Hypertension Due to Lung Diseases and Hypoxia Pulmonary Hypertension, Primary, 4 Pulmonary Hypertension, Primary, 2 Pulmonary Hypertension, Primary, 3 Chronic Thromboembolic Pulmonary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
2. The participant has a diagnosis of pulmonary hypertension confirmed by right heart catheterization
3. Patient is ≥ 18 years of age or older